Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes
Primary Purpose
Hemodynamics, Hyponatremia
Status
Completed
Phase
Phase 4
Locations
Canada
Study Type
Interventional
Intervention
Pico-Salax
Sponsored by
About this trial
This is an interventional diagnostic trial for Hemodynamics focused on measuring colonoscopy, preparation
Eligibility Criteria
Inclusion Criteria:
- healthy volunteers older than 45
Exclusion Criteria:
- impaired renal function
- congestive heart failure ascites known electrolyte abnormalities
Sites / Locations
- Hotel Dieu Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Pico-Salax
Arm Description
Outcomes
Primary Outcome Measures
serum electrolytes
patient hemodynamics
Secondary Outcome Measures
Full Information
NCT ID
NCT00885430
First Posted
April 20, 2009
Last Updated
September 18, 2015
Sponsor
Queen's University
Collaborators
Ferring Pharmaceuticals
1. Study Identification
Unique Protocol Identification Number
NCT00885430
Brief Title
Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes
Official Title
Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes
Study Type
Interventional
2. Study Status
Record Verification Date
September 2015
Overall Recruitment Status
Completed
Study Start Date
July 2008 (undefined)
Primary Completion Date
July 2008 (Actual)
Study Completion Date
September 2008 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Queen's University
Collaborators
Ferring Pharmaceuticals
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Twenty adult volunteers will be administered Pico-Salax in the usual fashion for colonoscopy with intense monitoring of serum and urine chemistry and hemodynamics.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hemodynamics, Hyponatremia
Keywords
colonoscopy, preparation
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Pico-Salax
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
Pico-Salax
Intervention Description
Two sachets of Pico-Salax given 5 hours apart
Primary Outcome Measure Information:
Title
serum electrolytes
Time Frame
48 hours
Title
patient hemodynamics
Time Frame
48 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
healthy volunteers older than 45
Exclusion Criteria:
impaired renal function
congestive heart failure ascites known electrolyte abnormalities
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lawrence Hookey, MD
Organizational Affiliation
Queen's University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hotel Dieu Hospital
City
Kingston
State/Province
Ontario
ZIP/Postal Code
K7L5G2
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes
We'll reach out to this number within 24 hrs